<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
66993-370-25
</NDCCode>
<PackageDescription>
25 VIAL in 1 CARTON (66993-370-25) / 1 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
66993-0370-25
</NDC11Code>
<ProductNDC>
66993-370
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Medroxyprogesterone Acetate
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Medroxyprogesterone Acetate
</NonProprietaryName>
<DosageFormName>
INJECTION, SUSPENSION
</DosageFormName>
<RouteName>
INTRAMUSCULAR
</RouteName>
<StartMarketingDate>
20210706
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA AUTHORIZED GENERIC
</MarketingCategoryName>
<ApplicationNumber>
NDA020246
</ApplicationNumber>
<LabelerName>
Prasco Laboratories
</LabelerName>
<SubstanceName>
MEDROXYPROGESTERONE ACETATE
</SubstanceName>
<StrengthNumber>
150
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Progesterone Congeners [CS], Progestin [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-01-08
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210706
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>